Specialties
Jon S Odorico, MD
Professor
- Section of Kidney and Pancreas Surgery
- Division of Transplantation
jon@surgery.wisc.edu
(608) 263-0388
Clinical Science Center
600 Highland Avenue
Madison WI 53792
Education
- MD, New York University, School of Medicine, New York, NY
- Residency, General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
- Postdoctoral Research Fellow, Harrison Department of Surgical Research, Hospital of the University of Pennsylvania, Philadelphia, PA
- Fellow, Transplant Surgery, University of Wisconsin Hospital and Clinics, Madison, WI
Honors
Best Doctors in America Award Surgery, Transplantation
Madison Magazine Top Docs 2012 Award Surgery, Transplantation
Avant-Garde Health General Surgery Research All-Stars (2024)
Clinical Specialties
Dr. Odorico is certified by the American Board of Surgery. He specializes in pancreatic, islet cell, and multi-organ transplants.
Dr. Odorico provides a wide range of services including Kidney Transplant, Pancreas Transplant.
Research Interests
Dr. Odorico’s research focuses on stem cell biology and differentiation, developing novel stem cell-based strategies for treating diabetes, pancreas transplantation, and islet cell transplantation.
Dr. Odorico’s lab
Clinical Trials
Conversion from Immediate Release Tacrolimus to Envarsus XR® in Simultaneous Pancreas-Kidney Recipients: Assessment of functional, safety and quality of life outcomes (CIRTEN SPK)
Study sponsor: University of Wisconsin-Madison
Study funding provided by: Veloxis Pharmaceuticals
Jon S. Odorico, MD, Principal Investigator
10/18/2018 –present
Non Invasive Blood Test to Diagnose Acute Rejection After Pancreas and Kidney Transplantation: Pancreas and Renal Rejection Diagnosis Using Circulating Donor-Derived Cell-free DNA in Peripheral Blood (PANCDx)
Study funding provided by: CareDx
Jon S. Odorico, MD, Sub-Investigator
Subcontract Agreement Amendment under negotiation, we expect to start enrollment in the first quarter of 2020
Recent Publications
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead.
Grattoni A, Korbutt G, Tomei AA, García AJ, Pepper AR, Stabler C, Brehm M, Papas K, Citro A, Shirwan H, Millman JR, Melero-Martin J, Graham M, Sefton M, Ma M, Kenyon N, Veiseh O, Desai TA, Nostro MC, Marinac M, Sykes M, Russ HA, Odorico J, Tang Q, Ricordi C, Latres E, Mamrak NE, Giraldo J, Poznansky MC, de Vos P
Nat Rev Endocrinol 2024 Sep 03;
[PubMed ID: 39227741]Cytomegalovirus Post-Prophylaxis Surveillance in High-Risk Kidney and Liver Recipients Prevents CMV End-Organ Disease and Ganciclovir-Resistance.
Jorgenson MR, Meyer E, Leverson GE, Descourouez JL, Saddler CM, Smith JA, Rice JP, Mandelbrot DA, Odorico JS
Clin Transplant 2024 Sep; 38(9): e15453
[PubMed ID: 39229690]Glucose Transporters Are Key Components of the Human Glucostat.
Caspi I, Tremmel DM, Pulecio J, Yang D, Liu D, Yan J, Odorico JS, Huangfu D
Diabetes 2024 Aug 01; 73(8): 1336-1351
[PubMed ID: 38775784]Indications, Techniques, and Barriers for Pancreas Transplant Biopsy: A Consensus Perspective From a Survey of US Centers.
Singh N, Lentine KL, Fleetwood VA, Woodside KJ, Odorico J, Axelrod D, Alhamad T, Maher K, Xiao H, Fridell J, Kukla A, Pavlakis M, Shokouh-Amiri HM, Zibari G, Cooper M, Parsons RF
Transplantation 2024 Jul 01; 108(7): e129-e138
[PubMed ID: 38467588]Incidence, Risk Factors, and Outcomes of Posttransplant Erythrocytosis Among Simultaneous Pancreas-Kidney Transplant Recipients.
Gibes ML, Astor BC, Odorico J, Mandelbrot D, Parajuli S
Transplant Direct 2024 Apr; 10(4): e1607
[PubMed ID: 38464426]